Status of serum magnesium and calcium in type 2 diabetes mellitus patients
DOI:
https://doi.org/10.18203/2320-6012.ijrms20261330Keywords:
Type 2 diabetes mellitus, Magnesium, Calcium, Mg/Ca ratioAbstract
Background: Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by persistently elevated blood sugar levels, resulting from inadequate insulin secretion, ineffective insulin action or both. Several studies have revealed association of hypomagnesaemia with poor glycemic control and various long-term complications of diabetes mellitus. Cohort studies have been found to be associated with higher serum Calcium levels with an increased risk of T2DM. Therefore, we aim to assess serum Mg and Ca status in Type 2 diabetes mellitus patients.
Methods: We conducted a case-control study with normal healthy population and T2DM patients visiting the OPD of Medicine. Normal healthy population and T2DM patients aged between 40 to 70 years of either sex were recruited and biochemical analysis was done.
Results: Total 80 participants (40 control and 40 T2DM patients) were recruited for the study. The mean age of the normal healthy population and T2DM patients was 53.07±10.79 and 55.72±9.86 years respectively. Non-significant change in BMI was observed in T2DM patients (26.49±4.35) as compared to normal healthy control (25.77±3.72). Significant increase (p<0.001) in fasting blood glucose and HbA1c was recorded in T2DM patients (222.55±75.63, 8.28±2.43 resp.) as compared to normal healthy control (92.33±8.53, 5.19±0.72 resp.). We observed non-significant decrease in serum Mg level and serum Ca level in T2DM patients (2.05±0.45, 8.68±0.76 resp.) as compared to normal healthy control (2.11±0.23, 8.99±0.77 resp), while Mg/Ca ratio was found unchanged in T2DM patients as compared to normal healthy control.
Conclusions: The study reveals a non-significant decrease in serum Mg and Ca in T2DM patients as compared to normal healthy population.
References
Yücel K, Gürbüz AF. Evaluation of calcium/magnesium ratio in patients with type 2 diabetes mellitus. Turkish Journal of Biochem. 2025;48(3):327-34.
Nielsen FH. Effects of magnesium depletion on inflammation in chronic disease. Curr Opin Clin Nutr Metab Care. 2014;17(6):525-30.
Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidn J. 2012;5(1):13-4.
Yücel K. Magnesium and its forms. In: Current biochemistry studies III. Ankara, Türkiye: Academician Bookstore. 2022: 49–63.
El-said NH, Sadik NA, Mohammed NA. Magnesium in type 2 diabetes mellitus and its correlation with glycemic control. Int J Res Med Sci. 2015;3(8):1958-63.
Kim DJ, Xun P, Liu K, Loria C, Yokota K, Jacobs Jr DR. Magnesium intake in relation to systemic inflammation, insulin resistance and the incidence of diabetes. Diabetes Care. 2010;33(12):2604-10.
Limaye CS, Londhey VA, Nadkart MY, Borges NE. Hypomagnesemia in critically ill medical patients. J Assoc Phys India. 2011;59:19-22.
Dasgupta A, Sarma D, Saikia UK. Hypomagnesemia in type 2 diabetes mellitus. Indian J Endocrinol Metabol. 2012;16(6):1000-3.
Huang JH, Lu YF, Cheng FC, Lee JN, Tsai LC. Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type 2 diabetes patients: a cross-sectional study. Nutr J. 2012;11:1-0.
Moradiya K, Muley A. A study of serum magnesium level in type 2 diabetes mellitus and its association with glycemic control and its complications. Int J Noncommun Dis. 2021;6(1):34-7.
Idevall-Hagren O, Tengholm A. Metabolic regulation of calcium signaling in beta cells. In Sem cell Dev Boil. 2020;103:20-30.
Reștea PA, Tigan Ș, Fritea L, Vicaș LG, Marian E, Mureșan ME. Serum calcium and magnesium levels in patients with type 2 diabetes and COVID-19 infection requiring hospitalization—correlations with various parameters. Microb Res. 2024;15(2):431-46.
Shah IU, Sameen A, Manzoor MF, Ahmed Z, Gao J, Farooq U. Association of dietary calcium, magnesium and vitamin D with type 2 diabetes among US adults: National health and nutrition examination survey 2007–2014—A cross‐sectional study. Food Sci Nutri. 2021;9(3):1480-90.
Brandão-Lima PN, Carvalho GB, Santos RK, Santos BD, Dias-Vasconcelos NL, Rocha VD. Intakes of zinc, potassium, calcium and magnesium of individuals with type 2 diabetes mellitus and the relationship with glycemic control. Nutrients. 2018;10(12):1948.
Escobedo-Monge MF, Barrado E, Parodi-Román J, Escobedo-Monge MA. Magnesium status and calcium/magnesium ratio in a series of cystic fibrosis patients. Nutrients. 2022;14(9):1793.
Meo SA, Memon AN, Sheikh SA, Rouq FA, Usmani A, Hassan A. Effect of environmental air pollution on type 2 diabetes mellitus. Eur Rev Med Pharmacol Sci. 2015;19:123–8.
Kostov K. Effects of magnesium deficiency on mechanisms of insulin resistance in type 2 diabetes: focusing on the processes of insulin secretion and signaling. Int J Mol Sci. 2019;20(6):1351.
Dong H, Lu N, Wang J, Hu P. Serum magnesium, not calcium, is inversely associated with abnormal HbA1c concentrations in adults with coronary artery disease. Asia Pacific J Clin Nutr. 2024;34(1):104.
Kieboom BCT, Ligthart S, Dehghan A. Serum magnesium and the risk of prediabetes: a population-based cohort study. Diabetol. 2017;60:843–53.
Li W, Zhu X, Song Y, Fan L, Wu L, Kabagambe EK. Intakes of magnesium, calcium and risk of fatty liver disease and prediabetes. Public health Nutr. 2018;21(11):2088-95.
Piuri G, Zocchi M, Della Porta M, Ficara V, Manoni M, Zuccotti GV. Magnesium in obesity, metabolic syndrome and type 2 diabetes. Nutrients. 2021;13(2):320.
Zamani M, Haghighat N. The effects of magnesium supplementation on serum magnesium and calcium concentration in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr Res. 2022;11(2):133.
Downloads
Published
How to Cite
Issue
Section
